158 related articles for article (PubMed ID: 36639701)
1. Significance of HLA in the development of Graves' orbitopathy.
Stasiak M; Zawadzka-Starczewska K; Tymoniuk B; Stasiak B; Lewiński A
Genes Immun; 2023 Feb; 24(1):32-38. PubMed ID: 36639701
[TBL] [Abstract][Full Text] [Related]
2. Significance of HLA in Graves' disease and Graves' orbitopathy in Asian and Caucasian populations - a systematic review.
Stasiak M; Stasiak B; Zawadzka-Starczewska K; Lewiński A
Front Immunol; 2023; 14():1256922. PubMed ID: 37841270
[TBL] [Abstract][Full Text] [Related]
3. Human leucocyte antigen alleles confer susceptibility and progression to Graves' ophthalmopathy in a Southern Chinese population.
Huang X; Liu G; Mei S; Cai J; Rao J; Tang M; Zhu T; Chen W; Peng S; Wang Y; Ye Y; Zhang T; Deng Z; Zhao J
Br J Ophthalmol; 2021 Oct; 105(10):1462-1468. PubMed ID: 33221730
[TBL] [Abstract][Full Text] [Related]
4. Associations between Lipid Profiles and Graves' Orbitopathy can Be HLA-Dependent.
Stasiak M; Zawadzka-Starczewska K; Tymoniuk B; Stasiak B; Lewiński A
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372389
[TBL] [Abstract][Full Text] [Related]
5. HLA-DRB1*03 is a susceptibility gene in patients with Graves' disease with and without ophthalmopathy.
Yarman S; Oguz F; Carin M
Int J Immunogenet; 2007 Feb; 34(1):23-5. PubMed ID: 17284224
[TBL] [Abstract][Full Text] [Related]
6. The role of major histocompatibility complex alleles in the susceptibility of Brazilian patients to develop the myogenic type of Graves' orbitopathy.
Akaishi PM; Cruz AA; Silva FL; Rodrigues Mde L; Maciel LM; Donadi EA
Thyroid; 2008 Apr; 18(4):443-7. PubMed ID: 18352820
[TBL] [Abstract][Full Text] [Related]
7. The association of HLA -A, -B, and -DRB1 genotypes with Graves' disease in Taiwanese people.
Huang SM; Wu TJ; Lee TD; Yang EK; Shaw CK; Yeh CC
Tissue Antigens; 2003 Feb; 61(2):154-8. PubMed ID: 12694583
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T
Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435
[TBL] [Abstract][Full Text] [Related]
9. Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds.
Maciel LM; Rodrigues SS; Dibbern RS; Navarro PA; Donadi EA
Thyroid; 2001 Jan; 11(1):31-5. PubMed ID: 11272094
[TBL] [Abstract][Full Text] [Related]
10. Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy.
Bednarczuk T; Hiromatsu Y; Seki N; Płoski R; Fukutani T; Kuryłowicz A; Jazdzewski K; Chojnowski K; Itoh K; Nauman J
Hum Immunol; 2004 Jun; 65(6):632-9. PubMed ID: 15219383
[TBL] [Abstract][Full Text] [Related]
11. HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective.
Chen QY; Huang W; She JX; Baxter F; Volpe R; Maclaren NK
J Clin Endocrinol Metab; 1999 Sep; 84(9):3182-6. PubMed ID: 10487684
[TBL] [Abstract][Full Text] [Related]
12. The association between HLA class II haplotype with Graves' disease in Thai population.
Wongsurawat T; Nakkuntod J; Charoenwongse P; Snabboon T; Sridama V; Hirankarn N
Tissue Antigens; 2006 Jan; 67(1):79-83. PubMed ID: 16451208
[TBL] [Abstract][Full Text] [Related]
13. HLA class II alleles in Japanese patients with Graves' disease: weak associations of HLA-DR and -DQ.
Katsuren E; Awata T; Matsumoto C; Yamamoto K
Endocr J; 1994 Dec; 41(6):599-603. PubMed ID: 7704083
[TBL] [Abstract][Full Text] [Related]
14. Identification of HLA-DRB1 alleles associated with Graves' disease in Koreans by sequence-based typing.
Jang HW; Shin HW; Cho HJ; Kim HK; Lee JI; Kim SW; Kim JW; Chung JH
Immunol Invest; 2011; 40(2):172-82. PubMed ID: 21062236
[TBL] [Abstract][Full Text] [Related]
15. Analysis of HLA class II genes in Hashimoto's thyroiditis reveals differences compared to Graves' disease.
Zeitlin AA; Heward JM; Newby PR; Carr-Smith JD; Franklyn JA; Gough SC; Simmonds MJ
Genes Immun; 2008 Jun; 9(4):358-63. PubMed ID: 18449200
[TBL] [Abstract][Full Text] [Related]
16. Genetic profiling in Graves' disease: further evidence for lack of a distinct genetic contribution to Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Davies TF
Thyroid; 2012 Jul; 22(7):730-6. PubMed ID: 22663548
[TBL] [Abstract][Full Text] [Related]
17. Interaction of HLA-DRB1* alleles and CTLA4 (+49 AG) gene polymorphism in Autoimmune Thyroid Disease.
Ramgopal S; Rathika C; Padma MR; Murali V; Arun K; Kamaludeen MN; Balakrishnan K
Gene; 2018 Feb; 642():430-438. PubMed ID: 29174716
[TBL] [Abstract][Full Text] [Related]
18. Critical amino acid variants in HLA-DRB1 allotypes in the development of Graves' disease and Hashimoto's thyroiditis in the Japanese population.
Katahira M; Ogata H; Takashima H; Ito T; Hodai Y; Miwata T; Goto M; Yamaguchi M; Mizoguchi A; Kawakubo M; Nakamura S
Hum Immunol; 2021 Apr; 82(4):226-231. PubMed ID: 33386169
[TBL] [Abstract][Full Text] [Related]
19. Actual Associations between HLA Haplotype and Graves' Disease Development.
Zawadzka-Starczewska K; Tymoniuk B; Stasiak B; Lewiński A; Stasiak M
J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566618
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive genotyping in two homogeneous Graves' disease samples reveals major and novel HLA association alleles.
Chen PL; Fann CS; Chu CC; Chang CC; Chang SW; Hsieh HY; Lin M; Yang WS; Chang TC
PLoS One; 2011 Jan; 6(1):e16635. PubMed ID: 21307958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
